Is Exxon Mobil Corporation (XOM) Currently a Good Investment Choice?
Exxon Mobil: Recent Performance and Outlook
Exxon Mobil (XOM) has recently attracted significant attention from investors, making it a popular topic among market watchers. Let’s explore the main factors that could influence the company’s short-term stock performance.
Recent Stock Movement
In the last month, Exxon Mobil’s share price has climbed by 8.4%. This contrasts with the Zacks S&P 500 composite, which declined by 5.7% over the same period. The international integrated oil and gas sector, which includes Exxon, saw an even stronger gain of 11.7%. The key question for investors is where the stock might head next.
What Drives Stock Trends?
While news headlines or speculation about major changes at a company can cause quick price swings, long-term investors often focus on fundamental factors. These underlying elements usually have a greater impact on a stock’s sustained performance.
Earnings Estimate Changes
Zacks places a strong emphasis on shifts in earnings forecasts when evaluating a company’s prospects. The rationale is that a stock’s fair value is closely tied to the present value of its expected future profits.
Our approach centers on how analysts update their earnings projections in response to new business developments. When these estimates rise, the perceived value of the stock typically increases, which can drive the price higher if the market hasn’t already adjusted. Research shows a close link between changes in earnings estimates and short-term stock price movements.
- For the current quarter, Exxon is projected to earn $1.66 per share, which is a 5.7% decrease from the same quarter last year. Over the past 30 days, this estimate has increased by 3.5%.
- The consensus forecast for the full fiscal year is $7.04 per share, up 0.7% year-over-year, with a 4.5% increase in the last month.
- Looking ahead, next year’s consensus estimate is $8.34 per share, reflecting an 18.4% increase from the previous year. This estimate has risen 1.6% in the past month.
Zacks’ proprietary rating system, the Zacks Rank, uses these earnings estimate trends as a key input. Exxon currently holds a Zacks Rank #3 (Hold), suggesting it may perform in line with the broader market in the near term.
Forward 12-Month EPS Trend
Revenue Growth Projections
While rising earnings are a strong indicator of financial health, sustained growth is difficult without increasing revenue. Understanding a company’s revenue outlook is therefore essential.
- For the current quarter, analysts expect Exxon to generate $82.47 billion in sales, a slight decrease of 0.8% from a year ago.
- Full-year revenue estimates are $331.8 billion for this year (down 0.1%) and $343.23 billion for next year (up 3.4%).
Recent Results and Earnings Surprises
In the most recent quarter, Exxon reported $82.31 billion in revenue, a 1.3% decline from the prior year. Earnings per share came in at $1.71, compared to $1.67 a year earlier.
- Revenue was 1.05% below the consensus estimate of $83.18 billion.
- EPS exceeded expectations by 1.79%.
- Exxon has surpassed consensus EPS estimates in each of the last four quarters.
Valuation Overview
Assessing whether a stock is fairly valued is crucial for investment decisions. Comparing valuation metrics like price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF) to historical averages and industry peers helps determine if a stock is undervalued, overvalued, or appropriately priced.
The Zacks Value Style Score, which grades stocks from A to F based on a range of valuation measures, is a useful tool for this analysis. Exxon currently receives a grade of C, indicating its valuation is in line with industry peers.
Conclusion
The information above, along with additional resources on Zacks.com, can help investors decide whether to pay attention to the current buzz around Exxon Mobil. With a Zacks Rank #3, the stock is expected to perform similarly to the overall market in the near term.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Time to Consider Purchasing MP Materials Shares at a Lower Price?

Toyota's $1 billion bet on Kentucky and Indiana plants
ASML’s Valuation Shift: BofA Raises Price Target Citing EUV-Led Margin Growth and Improved 2026 Outlook

FDA Grants Approval for Expanded Use of BMY's Opdivo in Treating Classical Hodgkin Lymphoma

